The State of Emerging Biotechs: Investment, Deal, and Pipeline Trends

This data-driven session from BIO and its market intelligence partner, Norstella, will dive into the state of play for emerging biotech companies. From venture capital and public financing, deal-making trends, and dynamics within the R&D pipeline, the panel will cover many of the themes that are most relevant to biotechs as they reach value inflection points, seek investment, and bring novel therapies closer to patients. Amid continued market suppression and new sources of competition, the challenge – and societal need – for a healthy innovative biotech ecosystem is greater than ever.